Topic

Lutathera (lutetium Lu-177 dotatate)

A collection of 30 issues

Getting Lutathera Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Approval Lutathera (lutetium Lu-177 dotatate) requires prior authorization from Cigna in New York. Your oncologist must document SSTR-positive imaging, well-differentiated neuroendocrine tumor pathology, and progression on somatostatin analog therapy. Standard approval takes 72 hours; expedited review takes 24 hours for urgent cases. If denied, you

How to Get Lutathera Approved by Blue Cross Blue Shield in Ohio: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Lutathera Covered in Ohio Lutathera requires prior authorization from Blue Cross Blue Shield in Ohio. Your fastest path to approval: (1) Confirm SSTR-positive imaging and documented progression on somatostatin analogs, (2) Submit complete PA request via Anthem provider portal with all clinical documentation, and (3) Allow 5-10

Renewing Lutathera Coverage with Cigna in New Jersey: Annual Requirements, Documentation, and Appeal Process

Answer Box: Lutathera renewal with Cigna requires annual reauthorization with comprehensive clinical documentation showing continued response and no disease progression. Submit renewal requests 30-45 days before your current authorization expires. Include updated imaging reports, lab results, oncologist notes, and confirmation you haven't exceeded the 4-dose lifetime limit. If

How to Get Lutathera (Lutetium Lu-177 Dotatate) Covered by UnitedHealthcare in California: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Lutathera Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Lutathera (lutetium Lu-177 dotatate) with step therapy documentation showing progression on somatostatin analogs. The fastest path to approval involves: 1. Submit PA request through the UnitedHealthcare Provider Portal with SSTR-positive imaging (Ga-68 DOTATATE PET/CT), pathology

How to Get Lutathera Covered by Aetna CVS Health in Illinois: Complete Prior Authorization Guide

Answer Box: Lutathera (lutetium Lu-177 dotatate) is covered by Aetna CVS Health in Illinois under the medical benefit with mandatory prior authorization. You'll need: confirmed somatostatin receptor-positive neuroendocrine tumor, documented failure of octreotide/lanreotide, and SSTR imaging results. Submit precertification 2+ weeks before treatment through Aetna's

Work With Your Doctor to Get Lutathera Covered by Blue Cross Blue Shield in Michigan: Provider Collaboration Guide

Answer Box: Getting Started Blue Cross Blue Shield of Michigan requires prior authorization for Lutathera (lutetium Lu-177 dotatate) for neuroendocrine tumors. Your best path: (1) Schedule a focused visit with your oncologist to review BCBSM's specific criteria, (2) gather required documentation including Ga-68 DOTATATE PET results and prior

How to Get Lutathera Covered by Aetna in Michigan: Prior Authorization Forms, Timelines & Appeals Guide

Quick Answer: Getting Lutathera Covered by Aetna in Michigan Lutathera (lutetium Lu-177 dotatate) requires prior authorization from Aetna in Michigan. The fastest path to approval: (1) Complete Aetna's Lutathera Precertification Form with detailed clinical documentation including SSTR-positive imaging, (2) Submit via Availity portal or fax to 1-888-267-3277 at

How to Get Lutathera (Lutetium Lu-177 Dotatate) Covered by UnitedHealthcare in Ohio: Complete Appeals Guide with Templates

Answer Box: Getting Lutathera Covered by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Lutathera (lutetium Lu-177 dotatate) with mandatory step therapy documentation showing progression on somatostatin analogs. In Ohio, you have 60 days to appeal denials internally, then 180 days for external review through the Ohio Department of Insurance.

How to Get Lutathera (Lutetium Lu-177 Dotatate) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Provider Collaboration Guide

Answer Box: Getting Lutathera Covered by Blue Cross Blue Shield in Pennsylvania Blue Cross Blue Shield plans in Pennsylvania (Highmark, Independence Blue Cross) require prior authorization for Lutathera (lutetium Lu-177 dotatate) with strict clinical criteria. Fastest approval path: Confirm you have GEP-NET diagnosis with SSTR-positive imaging, documented octreotide/lanreotide failure,

Work With Your Doctor to Get Lutathera (Lutetium Lu-177 Dotatate) Approved by UnitedHealthcare in Pennsylvania: Complete Provider Collaboration Guide

Quick Answer: Your Path to Lutathera Approval To get Lutathera (lutetium Lu-177 dotatate) covered by UnitedHealthcare in Pennsylvania, you'll need prior authorization showing somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors and documented progression on octreotide or lanreotide. Start today by: (1) requesting your complete medical records from your oncologist, (2)